Old variables, new value: a refined IPI for DLBCL

Blood. 2014 Feb 6;123(6):800-1. doi: 10.1182/blood-2013-12-540914.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Female
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / drug therapy*
  • Male
  • Practice Guidelines as Topic*
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab